Your browser doesn't support javascript.
loading
Identification of 27 allele-specific regulatory variants in Parkinson's disease using a massively parallel reporter assay.
Farrow, Sophie L; Gokuladhas, Sreemol; Schierding, William; Pudjihartono, Michael; Perry, Jo K; Cooper, Antony A; O'Sullivan, Justin M.
Afiliação
  • Farrow SL; Liggins Institute, The University of Auckland, Auckland, New Zealand. s.farrow@auckland.ac.nz.
  • Gokuladhas S; The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand. s.farrow@auckland.ac.nz.
  • Schierding W; Liggins Institute, The University of Auckland, Auckland, New Zealand.
  • Pudjihartono M; Liggins Institute, The University of Auckland, Auckland, New Zealand.
  • Perry JK; The Maurice Wilkins Centre, The University of Auckland, Auckland, New Zealand.
  • Cooper AA; Department of Ophthalmology, The University of Auckland, Auckland, New Zealand.
  • O'Sullivan JM; Liggins Institute, The University of Auckland, Auckland, New Zealand.
NPJ Parkinsons Dis ; 10(1): 44, 2024 Feb 27.
Article em En | MEDLINE | ID: mdl-38413607
ABSTRACT
Genome wide association studies (GWAS) have identified a number of genomic loci that are associated with Parkinson's disease (PD) risk. However, the majority of these variants lie in non-coding regions, and thus the mechanisms by which they influence disease development, and/or potential subtypes, remain largely elusive. To address this, we used a massively parallel reporter assay (MPRA) to screen the regulatory function of 5254 variants that have a known or putative connection to PD. We identified 138 loci with enhancer activity, of which 27 exhibited allele-specific regulatory activity in HEK293 cells. The identified regulatory variant(s) typically did not match the original tag variant within the PD associated locus, supporting the need for deeper exploration of these loci. The existence of allele specific transcriptional impacts within HEK293 cells, confirms that at least a subset of the PD associated regions mark functional gene regulatory elements. Future functional studies that confirm the putative targets of the empirically verified regulatory variants will be crucial for gaining a greater understanding of how gene regulatory network(s) modulate PD risk.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Parkinsons Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Parkinsons Dis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia